Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Merck & Co Inc

+ Add to Watchlist

MRK:US

58.9700 USD 0.4100 0.69%

As of 20:04:06 ET on 05/26/2015.

Snapshot for Merck & Co Inc (MRK)

Open: 59.2800 Day's Range: 58.8500 - 59.4400 Volume: 10,857,710
Previous Close: 59.3800 52wk Range: 52.4900 - 63.6200 1-Yr Rtn: +7.23%

Stock Chart for MRK

No chart data available.
  • MRK:US 58.9700
  • 1D
  • 1M
  • 1Y
59.3800
Interactive MRK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MRK

Current P/E Ratio (ttm) 30.1876
Estimated P/E(12/2015) 17.1424
Relative P/E vs. SPX 1.6236
Earnings Per Share (USD) (ttm) 1.9535
Est. EPS (USD) (12/2015) 3.4400
Est. PEG Ratio 2.6052
Market Cap (M USD) 166,603.33
Shares Outstanding (M) 2,825.22
30 Day Average Volume 10,639,501
Price/Book (mrq) 3.4919
Price/Sale (ttm) 4.1010
Dividend Indicated Gross Yield 3.05%
Cash Dividend (USD) 0.4500
Dividend Ex-Date 06/11/2015
5 Year Dividend Growth 3.21%
Next Earnings Announcement 07/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MRK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MRK

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company has operations in pharmaceutical, animal health, and consumer care.

Kenneth C Frazier "Ken"Chairman/President/CEORobert M Davis "Rob"Exec VP/CFO
Clark GolestaniExec VP/Chief Information OfcrMichael J HolstonExec VP/Chief Ethics Ofcr
More Company Profile & Key Executives for MRK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil